Domiciliary Hospitalization Claims — When Hospital Treatment Moves Home
Definition
Domiciliary hospitalization refers to medical treatment that a patient receives at home under circumstances where the patient would normally require hospitalization but cannot be moved to a hospital due to the severity of the condition, the patient's inability to be transported, or the unavailability of hospital beds. Under IRDAI guidelines, domiciliary treatment is covered under health insurance when it meets specific criteria: the treatment must be for a condition that would otherwise require hospitalization, and the treatment must continue for a minimum period (typically 3 or more consecutive days) with active medical supervision, including regular doctor visits, nursing care, and diagnostic monitoring at the patient's residence.
Domiciliary hospitalization gained significant prominence during the COVID-19 pandemic when hospital beds were unavailable across India, and thousands of patients received treatment at home under medical supervision. IRDAI issued specific guidelines mandating insurers to cover COVID-19 domiciliary treatment. The claim process for domiciliary hospitalization is primarily through the reimbursement route, as cashless arrangements are not typically available for home-based treatment. The documentation requirements are more stringent than regular hospitalization claims because the insurer needs to verify that the treatment at home was medically justified and equivalent to hospital-level care.
Explanation in Simple Language
Domiciliary hospitalization is essentially bringing the hospital to the patient's home. This happens in situations where moving the patient to a hospital is either medically risky, practically impossible, or when hospitals simply do not have beds available. During the COVID-19 second wave in April-May 2021, India witnessed an unprecedented hospital bed crisis. Patients with moderate to severe COVID symptoms were treated at home with oxygen concentrators, IV medications, regular doctor visits, and nurse monitoring — all of which constituted domiciliary hospitalization.
The key challenge with domiciliary claims is proving that the treatment was hospital-equivalent. Insurers scrutinize these claims more carefully because there is a risk of misuse — a patient receiving simple home nursing care might try to claim it as domiciliary hospitalization. To qualify, the treatment must involve: (a) a condition that genuinely requires hospitalization, (b) active treatment by a qualified medical practitioner with regular visits, (c) medication and procedures equivalent to hospital treatment, and (d) a continuous treatment period of at least 3 days. The treating doctor must provide a detailed certificate explaining why hospitalization was not possible and confirming that the treatment administered was equivalent to hospital care.
Real-Life Indian Example
Mr. Harish Patel, a 72-year-old retired businessman from Ahmedabad, contracted COVID-19 during the devastating second wave in April 2021. His oxygen saturation dropped to 88%, requiring supplemental oxygen. His family tried to get him admitted to five hospitals in Ahmedabad — Civil Hospital, Sterling Hospital, Zydus Hospital, Apollo Hospital, and CIMS Hospital — but all had zero bed availability.
His family physician, Dr. Mehta, arranged for home treatment: an oxygen concentrator (rented at Rs. 1,200/day), pulse oximeter, IV medications (Remdesivir — Rs. 5,000 per vial, 5 vials administered), oral medications (Favipiravir, Dexamethasone, blood thinners), daily nurse visits (Rs. 1,500/day), and Dr. Mehta's daily visits (Rs. 800/visit). The treatment continued for 14 days at home.
Total expenses: Rs. 2,15,000. Mr. Patel had a New India Assurance policy with Rs. 5 lakh sum insured. He submitted a domiciliary hospitalization claim with Dr. Mehta's certificate confirming unavailability of hospital beds and the medical necessity of home treatment. New India Assurance, following IRDAI's COVID domiciliary guidelines, approved Rs. 1,88,000 (deducting Rs. 27,000 for non-medical expenses like food supplements and sanitizers). The amount was reimbursed within 35 days.
Numerical Example
Domiciliary Hospitalization Claim — COVID-19 Home Treatment Breakdown:
Medical Expenses (14-day home treatment):
- Doctor visits (14 days @ Rs. 800/visit): Rs. 11,200
- Nurse visits (14 days @ Rs. 1,500/day): Rs. 21,000
- Oxygen concentrator rental (14 days @ Rs. 1,200/day): Rs. 16,800
- Remdesivir injections (5 vials @ Rs. 5,000): Rs. 25,000
- IV fluids and administration kits (14 days): Rs. 8,400
- Oral medications (Favipiravir, Dexamethasone, Ivermectin, blood thinners): Rs. 12,600
- Diagnostic tests (RT-PCR, CT scan at home, blood tests x 4): Rs. 14,000
- Pulse oximeter purchase: Rs. 2,500
- Steam inhaler and nebulizer rental: Rs. 3,500
- Subtotal Medical: Rs. 1,15,000
Non-Medical Expenses:
- PPE kits for nurse/doctor (14 days): Rs. 7,000
- Sanitizers, masks, gloves: Rs. 3,500
- Special nutrition supplements: Rs. 8,000
- Room sanitization: Rs. 4,000
- Subtotal Non-Medical: Rs. 22,500
Total Expenses: Rs. 1,37,500
Insurer Assessment:
- Medical expenses approved: Rs. 1,12,000 (pulse oximeter capped at Rs. 1,500)
- Non-medical expenses: Rs. 7,000 (PPE kits approved as medical necessity during COVID)
- Total Approved: Rs. 1,19,000
- Total Rejected: Rs. 18,500 (sanitizers, nutrition supplements, room sanitization, oximeter excess)
- Reimbursement Amount: Rs. 1,19,000
Policy Clause Reference
IRDAI Guidelines on Domiciliary Hospitalization: (1) Domiciliary treatment is covered when the condition of the patient is such that he/she cannot be moved to a hospital or there is no bed available in a hospital. (2) The treatment must be for a minimum continuous period of 3 days (some policies specify different minimums). (3) The treating doctor must certify in writing the medical necessity for domiciliary treatment and the reason why hospitalization was not possible. (4) COVID-19 Domiciliary Treatment: IRDAI Circular IRDAI/HLT/MISC/CIR/P&D/164/07/2020 mandated coverage of COVID-19 domiciliary treatment when hospital admission is not possible. (5) Expenses for medicines, diagnostic tests, doctor fees, nursing charges, and medical equipment rental used during domiciliary treatment are covered. (6) The claim process is through reimbursement mode with original bills and the treating doctor's certificate.
Claim Scenario
Mrs. Kamla Devi, a 78-year-old bedridden patient from Varanasi, had been suffering from advanced Parkinson's disease. She developed a severe urinary tract infection with high fever (103 degrees F). Her neurologist and general physician both agreed that moving her to a hospital would be extremely risky due to her immobility and fragile condition.
Her son arranged for home treatment: a visiting physician came twice daily for 10 days, a nurse was hired for 12-hour shifts, IV antibiotics were administered at home, urine culture and blood tests were conducted at home by a pathology lab, and a portable ECG was done to monitor her heart. Total expenses: Rs. 95,000.
The family submitted a domiciliary hospitalization claim under Mrs. Kamla Devi's IFFCO Tokio policy (Rs. 3 lakh sum insured). They included a detailed certificate from both the neurologist and the physician explaining why hospitalization was not feasible. IFFCO Tokio approved Rs. 82,000 after deducting nursing charges for non-treatment hours and the cost of adult diapers (classified as non-medical consumable). The claim was settled in 28 days.
Common Rejection Reason
Common reasons for domiciliary hospitalization claim rejection: (1) No medical certificate from the treating doctor explaining why hospitalization was not possible — this is the single most important document and its absence leads to automatic rejection. (2) Treatment duration less than the policy-specified minimum (typically 3 consecutive days) — a 2-day home treatment does not qualify. (3) Condition does not warrant hospitalization — if the illness could have been treated with OPD visits and oral medication, domiciliary claim is not valid. (4) No regular medical supervision — occasional doctor visits without structured treatment protocol do not constitute domiciliary hospitalization. (5) Bills and receipts are from multiple unrelated providers without a coordinating physician — raises suspicion of fabricated claims.
Legal / Arbitration Angle
In the Insurance Ombudsman Award IO/HYD/A/HI/2021/0923, the Ombudsman ruled in favor of a COVID-19 patient whose domiciliary claim was rejected by Star Health on the grounds that "home treatment does not qualify as hospitalization." The Ombudsman cited IRDAI's COVID-19 domiciliary circular and directed Star Health to pay Rs. 1,65,000 within 15 days, noting that the insurer's rejection was a direct violation of IRDAI guidelines.
In Bajaj Allianz vs. Mr. Subramaniam (State Consumer Commission, Tamil Nadu, 2020), the Commission held that domiciliary hospitalization cannot be denied merely because the patient chose home treatment over hospital admission. If the treating doctor certifies that hospital-equivalent treatment was provided at home and the medical condition warranted such treatment, the insurer must honor the claim. The insurer was directed to pay Rs. 2,10,000 plus 9% interest from the date of claim rejection.
Court Case Reference
New India Assurance vs. Indu Sharma (NCDRC, 2021) — The National Consumer Disputes Redressal Commission ruled that during a declared pandemic or medical emergency, the unavailability of hospital beds is a presumed fact and the insurer cannot require the policyholder to provide documentary proof (like hospital rejection letters) for every hospital in the city. The Commission held that a single certificate from the treating doctor stating bed unavailability, supported by contemporary news reports and government advisories about hospital bed shortage, is sufficient to establish the ground for domiciliary hospitalization. The insurer was directed to pay the full domiciliary claim of Rs. 2,45,000.
Common Sales Mistakes
Mistakes POSPs make regarding domiciliary hospitalization: (1) Not mentioning domiciliary coverage at all during the sale — customers discover this benefit only when they need it, and by then they do not know the documentation requirements. (2) Overstating the coverage — telling customers "any treatment at home is covered" without explaining the strict conditions (medical necessity, doctor certificate, minimum duration). (3) Not clarifying that domiciliary claims are reimbursement-only — customers expect cashless treatment at home, which is not available. (4) Failing to explain the documentation burden — domiciliary claims require more extensive documentation than hospital claims, and customers need to be prepared. (5) Not knowing the policy-specific minimum treatment duration — some policies require 3 days, others 5 days.
Claims Dispute Example
Mr. Arun Khanna from Delhi had an ICICI Lombard policy with Rs. 10 lakh sum insured. During the COVID-19 second wave, he was treated at home for 12 days. His total expenses were Rs. 3,20,000 including oxygen concentrator rental, Remdesivir, nurse charges, and doctor visits.
ICICI Lombard approved only Rs. 1,80,000, rejecting Rs. 1,40,000 on the following grounds: (a) oxygen concentrator rental was "excessive" at Rs. 1,500/day (they approved Rs. 800/day), (b) nurse charges were "above market rate" (approved Rs. 1,000/day instead of Rs. 2,000/day), and (c) two Remdesivir vials were "not medically necessary" as per the insurer's medical opinion.
Mr. Khanna approached the Insurance Ombudsman with rental receipts, the nurse's employment contract, and the treating doctor's prescription for all 6 Remdesivir vials. The Ombudsman found that during the COVID peak, oxygen concentrator rental rates in Delhi were Rs. 1,200-Rs. 2,000/day, nurse charges were Rs. 1,500-Rs. 2,500/day, and the treating doctor had clearly prescribed 6 vials. The Ombudsman directed ICICI Lombard to pay Rs. 2,85,000 (deducting only Rs. 35,000 for genuinely non-medical expenses like sanitizers and nutrition supplements).
Learning for POSP / Advisor
Domiciliary hospitalization is an under-explained benefit that becomes critically important in emergencies. POSPs should: (1) Explain the concept of domiciliary coverage at the time of policy sale — most customers do not know this benefit exists. (2) Clarify the conditions: the treatment must be hospital-equivalent, the patient must be unable to go to a hospital, and the treating doctor must certify the necessity. (3) During COVID-19 or any future pandemic, proactively reach out to policyholders to inform them about domiciliary claim eligibility. (4) Guide customers on documentation — the doctor's certificate is the make-or-break document. (5) Help elderly customers or their family members understand that bedridden patients can receive insured treatment at home. (6) Emphasize that this is a reimbursement process — customers need to pay upfront and keep all original bills.
Summary Notes
-- Domiciliary hospitalization covers treatment at home when the patient cannot go to a hospital.
-- Valid grounds: medical risk in moving the patient, patient immobility, unavailability of hospital beds.
-- Minimum treatment duration: typically 3 consecutive days (check specific policy terms).
-- Claims are processed through reimbursement mode only — no cashless available.
-- The treating doctor's certificate is the most critical document.
-- COVID-19 pandemic highlighted the importance of domiciliary coverage.
-- IRDAI issued specific circulars mandating COVID domiciliary treatment coverage.
-- Documentation must include: doctor certificate, prescriptions, bills, diagnostic reports, nurse logs.
-- Insurers scrutinize domiciliary claims more carefully — thorough documentation is essential.
-- POSPs should explain this benefit at the time of policy sale and help with documentation during claims.
Case Study Questions
Q1.A 75-year-old bedridden patient with advanced COPD develops a respiratory infection requiring IV antibiotics and oxygen support. The family decides on home treatment because moving the patient to a hospital poses a risk of worsening the condition. The domiciliary treatment lasts 10 days with total expenses of Rs. 1,45,000. The insurer rejects the claim stating the family "chose" home treatment and could have called an ambulance. Draft the policyholder's appeal to the Insurance Ombudsman, including the medical arguments and IRDAI guidelines that support the claim.
Q2.During a hypothetical future pandemic, a policyholder receives domiciliary treatment for 8 days. The insurer approves only 5 days, arguing that the patient's condition improved after day 5 and the remaining 3 days were "convalescence, not treatment." The treating doctor's certificate states that all 8 days involved active treatment. Analyze the merits of the policyholder's case and the insurer's argument, and predict the likely Ombudsman outcome based on COVID-19 precedents.